Congress Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$17.3M	Buy	38,915 +4,801	+14%	+$2.21M	0.17%	149
2025 Q1	$16.6M	Buy	34,114 +7,021	+26%	+$3.27M	0.2%	132
2024 Q4	$10.9M	Sell	27,093 -8,155	-23%	-$3.78M	0.15%	186
2024 Q3	$16.4M	Buy	35,248 +3,469	+11%	+$1.67M	0.22%	135
2024 Q2	$14.9M	Buy	31,779 +29,371	+1,220%	+$12.7M	0.24%	120
2024 Q1	$1.01M	Buy	2,408 +1,328	+123%	+$561K	0.02%	374
2023 Q4	$440K	Buy	1,080 +280	+35%	+$103K	0.01%	483
2023 Q3	$279K	Buy	800 +57	+8%	+$19.9K	0.01%	534
2023 Q2	$262K	Buy	743 +80	+12%	+$27K	0.01%	500
2023 Q1	$209K	Sell	663 -163	-20%	-$48.9K	0.01%	534
2022 Q4	$239K	Buy	826 +115	+16%	+$35K	0.01%	515
2022 Q3	$206K	Buy	+711	New	+$205K	0.01%	524
2022 Q2	–	Sell	-1,025	Closed	-$267K	–	622
2022 Q1	$267K	Buy	1,025 +3	+0.3%	+$712	0.01%	533
2021 Q4	$224K	Buy	+1,022	New	+$199K	﹤0.01%	579